24 Jul, EOD - Indian

SENSEX 80148.88 (-0.35)

Nifty 50 24413.5 (-0.27)

Nifty Bank 51317 (-0.89)

Nifty IT 40115.05 (0.18)

Nifty Midcap 100 56872.75 (1.04)

Nifty Next 50 71844.65 (0.30)

Nifty Pharma 20908.5 (0.74)

Nifty Smallcap 100 18723.5 (1.76)

24 Jul, EOD - Global

NIKKEI 225 39154.85 (-1.11)

HANG SENG 17311.05 (-0.91)

DOW JONES 39963.71 (-0.98)

S&P 5462.31 (-1.68)

New Issue Monitor


(02 Jul 2024, 09:47)

Emcure Pharmaceuticals

Established presence in major therapeutic areas

Emphasizing chronic and sub-chronic therapies for higher growth

CM RATING 45 / 100
Reckoner

Incorporated in 1981, Emcure is an Indian pharmaceutical company developing, manufacturing, and marketing worldwide a diverse range of pharmaceutical products across several therapeutic areas.

Emcure has established presence in major therapeutic areas including gynecology, cardiovascular, vitamins, minerals and nutrients, HIV antivirals, blood-related and oncology and anti-neoplastics. Gynecology contributed 24.09%, cardiovascular 15.7%, anti-infectives 10.97%, vitamins, minerals and nutrients 8.97%, HIV antivirals 6.85%, respiratory 6.35%, gastrointestinal 6.35%, pain and analgesics 5.48%, blood-related 3.84%, oncology and anti-neoplastics 4.46%, anti-diabetic 2.58%, hormones 1.77%, neurology/CNS 1.27%, and others 1.5% to domestic sales in FY 2024....



More News
More Company News